Patient-reported Outcomes of Cemiplimab versus Chemotherapy in Advanced NSCLC: PD-L1 Level Subgroups in EMPOWER-Lung 1


Kilickap S., Sezer A., GÜMÜŞ M., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.17, no.9, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 17 Issue: 9
  • Publication Date: 2022
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Keywords: non-small cell lung cancer, patient-reported outcomes, cemiplimab
  • Istanbul University Affiliated: No